239 related articles for article (PubMed ID: 21911444)
1. Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.
Ru P; Steele R; Nerurkar PV; Phillips N; Ray RB
Cancer Prev Res (Phila); 2011 Dec; 4(12):2122-30. PubMed ID: 21911444
[TBL] [Abstract][Full Text] [Related]
2. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
Brennan VC; Wang CM; Yang WH
J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
[TBL] [Abstract][Full Text] [Related]
3. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.
Xiong SD; Yu K; Liu XH; Yin LH; Kirschenbaum A; Yao S; Narla G; DiFeo A; Wu JB; Yuan Y; Ho SM; Lam YW; Levine AC
Int J Cancer; 2009 Aug; 125(4):774-82. PubMed ID: 19384952
[TBL] [Abstract][Full Text] [Related]
4. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
Raina K; Singh RP; Agarwal R; Agarwal C
Cancer Res; 2007 Jun; 67(12):5976-82. PubMed ID: 17575168
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
[TBL] [Abstract][Full Text] [Related]
6. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
Ray RB; Raychoudhuri A; Steele R; Nerurkar P
Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
[TBL] [Abstract][Full Text] [Related]
8. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
[TBL] [Abstract][Full Text] [Related]
9. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Cancer Lett; 2011 Jul; 306(2):142-50. PubMed ID: 21429659
[TBL] [Abstract][Full Text] [Related]
10. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
[TBL] [Abstract][Full Text] [Related]
11. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Food Chem Toxicol; 2012 Mar; 50(3-4):840-7. PubMed ID: 22266361
[TBL] [Abstract][Full Text] [Related]
12. The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model.
Zuniga KE; Clinton SK; Erdman JW
Cancer Prev Res (Phila); 2013 Jun; 6(6):548-57. PubMed ID: 23592738
[TBL] [Abstract][Full Text] [Related]
13. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV
Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854
[TBL] [Abstract][Full Text] [Related]
15. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
16. Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model.
Khor TO; Yu S; Barve A; Hao X; Hong JL; Lin W; Foster B; Huang MT; Newmark HL; Kong AN
Cancer Res; 2009 Sep; 69(17):7096-102. PubMed ID: 19706764
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
[TBL] [Abstract][Full Text] [Related]
18. Murine prostate cancer inhibition by dietary phytochemicals--curcumin and phenyethylisothiocyanate.
Barve A; Khor TO; Hao X; Keum YS; Yang CS; Reddy B; Kong AN
Pharm Res; 2008 Sep; 25(9):2181-9. PubMed ID: 18437538
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.
Sur S; Nakanishi H; Flaveny C; Ippolito JE; McHowat J; Ford DA; Ray RB
Cell Commun Signal; 2019 Oct; 17(1):131. PubMed ID: 31638999
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.
Kang BH; Tavecchio M; Goel HL; Hsieh CC; Garlick DS; Raskett CM; Lian JB; Stein GS; Languino LR; Altieri DC
Br J Cancer; 2011 Feb; 104(4):629-34. PubMed ID: 21285984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
